ORJ-001 achieved therapeutic exposure and was well tolerated in Phase 1 study, supporting company’s plans to initiate Phase 2 clinical trial in IPF patients Data from preclinical studies of ORJ-001 ...
Verywell Health on MSN
What are alveoli?
What these tiny sacs in the lungs do and conditions that can affect them ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results